Factors associated with clinical trial participation in hematopoietic stem cell transplantation (HSCT) recipients: A CIBMTR analysis.
Citation
Fowler TF, Brazauskas R, Patel J, Rangarajan HG, Michelis FV, Battiwalla M, Lehmann LE, Stefanski HE, Dias AL, Sharma A, Beitinjaneh A, Zeidan AM, Gómez-De León A, Saad A, Hamilton BK, Marks DI, Rizzieri DA, Szwajcer D, Lad DP, Hildebrandt GC, Hashem H, Murthy HS, Liu H, Preussler JM, Yared JA, Aljurf M, de Lima M, Krem MM, Herr MM, Solh M, 31. Abid MB, Ramanathan M, El Jurdi N, Khera N, Majahil NS, Lulla P, Seo S, Hong S, Chhabra S, Ganguly S, Gergis U, Agrawal V, El-Jawahri AR, Saber W.
Journal of the National Comprehensive Cancer Network (JNCCN). 2026, Oct 22: (): :e267054. doi: 10.6004/jnccn.2026.7054. Epub 2026, Oct 22. PMCID:.
PubMed
PMID: 42913707
Abstract
